Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

7.780 +0.490 (+6.73%)
Streaming Delayed Price Updated: 11:22 AM EDT, Sep 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 4 Next >
News headline image
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
New functionality helps DSPs and agency planners create deterministic HCP and consumer audiences faster, using one single workflow 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
Experienced pharmaceutical and healthcare executive joins advisory board to help accelerate innovation and strengthen life sciences marketing technology 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
Leading pharmaceutical marketing executive joins leadership team to accelerate innovation and strengthen partnerships across the life sciences industry 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
Enhanced technology delivers brand savings offers directly within the prescribing workflow, when HCP intent is highest 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
Patent-pending, embeddable NLAB technology enables pharma and agency marketers to build custom, verified HCP audiences using natural-language prompts 
From OptimizeRx Corporation
Via GlobeNewswire
MissionIRNewsBreaks – OptimizeRx Corp. (NASDAQ: OPRX) Secures $35 Million Senior Credit Facility
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
Powered by OptimizeRx’s new programmatic infrastructure, collaboration expands access to premium point of care inventory for life sciences marketers 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
Expands life sciences marketers’ reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx’s trusted EHR network for the first time 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing
Life science marketers will be able to better measure the exposed audiences for a more complete, accurate, and transparent view of campaign engagement and effectiveness 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network
Strategic Partnerships Add Exclusivity in Leading EHR, e-Prescription, and Technology Companies, Increasing NPI Reach by 37% 
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors
From OptimizeRx Corporation
Via GlobeNewswire
News headline image
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions
From Simulmedia
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.